Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inotiv (NOTV) Raw Materials (2021 - 2026)

Inotiv filings provide 6 years of Raw Materials readings, the most recent being $1.6 million for Q1 2026.

  • On a quarterly basis, Raw Materials fell 28.76% to $1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.6 million, a 28.76% decrease, with the full-year FY2025 number at $1.7 million, down 11.62% from a year prior.
  • Raw Materials hit $1.6 million in Q1 2026 for Inotiv, down from $1.7 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $2.4 million in Q4 2022 to a low of $1.6 million in Q1 2026.
  • Median Raw Materials over the past 5 years was $1.9 million (2022), compared with a mean of $2.0 million.
  • Biggest five-year swings in Raw Materials: surged 242.5% in 2022 and later dropped 28.76% in 2026.
  • Inotiv's Raw Materials stood at $2.4 million in 2022, then decreased by 8.7% to $2.2 million in 2023, then dropped by 15.57% to $1.8 million in 2024, then dropped by 7.0% to $1.7 million in 2025, then dropped by 8.86% to $1.6 million in 2026.
  • The last three reported values for Raw Materials were $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $1.7 million (Q3 2025) per Business Quant data.